IWK Health Centre
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, IWK Health Centre sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
IWK Health Centre: 3 sponsored US clinical trials, 1 recruiting.
IWK Health Centre sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Patent Ductus Arteriosus After Premature Birth, with 1 trials.
Upper-quartile sponsor footprint
IWK Health Centre sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT
NCT05011149
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
NCT01481740
Synera™ for Epidural Needle Insertion
NCT00564785
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
Where IWK Health Centre enrollment is open (later-stage tilt)
1 recruiting of 3 indexed (33% open); 2 completed (67%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Patent Ductus Arteriosus After Premature Birth (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
IWK Health Centre: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
IWK Health Centre sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this IWK Health Centre page
3 registered trials is a research-attention snapshot, not an endorsement of IWK Health Centre or any single study.
- 1 of IWK Health Centre's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Patent Ductus Arteriosus After Premature Birth is the condition IWK Health Centre studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Patent Ductus Arteriosus After Premature Birth trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. IWK Health Centre pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.